Horrendous hemorrhagic complications with OAC in ESRD with AFib : “The 1-year rates for major or clinically relevant non-major bleeding were 32% and 26% in apixaban and warfarin groups, respectively”. Worse mortality for apixaban as well (26% vs 18%) ahajournals.org/doi/10.1161/CI….

Lower risk of first spontaneous ICH with statin use regardless of location (ie, lobar or non-lobar) reported in our article in #Neurology: n.neurology.org/content/early/… The study was supported by Novo Nordic Foundation #novonordiskfonden #AANscience #NeuroTwitter @SUND_SDU OUH Odense Svendborg

More emerging data from Drs. Boe, Gaist, and colleagues supporting the heightened cardiovascular risk in ICH survivors. Enjoyed writing this invited commentary with Weill Cornell Neurology chief resident Marialaura Simonetto JAMA Network Open jamanetwork.com/journals/jaman…

Interested in risk of major cardiovascular events after intracerebral hemorrhage? See our article in JAMA Network Open: jamanetwork.com/journals/jaman… The study was supported by Novo Nordic Foundation #novonordiskfonden. #NeuroTwitter @SUND_SDU OUH Odense Svendborg

...and invited commentary by Simonetto & Murthy jamanetwork.com/journals/jaman…

Great work Alexander Benz ! academic.oup.com/eurheartj/adva… The findings of this high-quality RCT dataset are in line with previous data confirming very high stoke risk of AF patients with breakthrough strokes on anticoagulation Urs Martin Fischer Thomas Meinel Stroke Research Center Bern

👏👏👏 well done Luciano Sposato 🇦🇷🇨🇦 and team! Intriguing results!

Another terrific paper from the Boston CAA group - superficial siderosis marks high vs low risk of ICH recurrence in the presence of mixed deep and lobar microbleeds. n.neurology.org/content/101/6/…

Use of statins and risk of recurrent stroke after an intracerebral hemorrhage. Interested? See our article in #Neurology: n.neurology.org/content/early/… The study was supported by Novo Nordic Foundation #novonordiskfonden. #AANscience #NeuroTwitter @SUND_SDU OUH Odense Svendborg Neurology Journal

Prestigious Award! ⁦Rolf Blauenfeldt⁩ just won the “Young Researcher Award” at The Danish Neurological Society meeting! 👊🏽

A multidisciplinary collaboration where the specialties who contribute are appropriately credited and honored. This is what excellence looks like. Bravo, CADMUS investigators. #neurovascular #neurology #neuroradiology

New paper out! Is triptan use associated with major ischemic events? Yes, but the risk is very low and limited to people aged 60+ with high cardiovascular risk. European Stroke Org David Gaist HerlevGentofte Hosp.

The scientific program is now avaible of International 8th Turkish Stroke Academy and Teaching Courses strokeacademy2024.org #tcvds #turkishcerebrovasculardiseasessociety #Turkishstrokeacademy #8thTurkishScrokeAcademy

The ANNEXa-I primary results manuscript is now available NEJM. nejm.org/doi/full/10.10… #stroke #neurotwitter @McMasterStroke McMaster University Department of Medicine PHRI.ca Population Health Research Institute 🇨🇦 David Seiffge Else C. Sandset Mike Sharma Andrew Demchuk Carlos Molina Professor Hanne Christensen @robinlemmens

"Stroke is projected to account for the largest absolute increase in healthcare costs by 2050."

Left atrial appendage closure in patients with atrial fibrillation and acute ischaemic stroke despite anticoagulation Alvin Das Edip Gurol svn.bmj.com/content/early/…

We followed >8000 Danes with atrial fibrillation who had a stroke and started/restarted DOAC. For incidence rates of stroke recurrence, association of recurrence with DOAC discontinuation & more, see our article in #JAMA Neurology: jamanetwork.com/journals/jaman…

AI can detect stroke in MRI! Read more: doi.org/10.1186/s13244… #AI #stroke #MRI #neuroradiology in Insights into Imaging

The first step towards 4,148 participants! Ashkan Shoamanesh British Heart Foundation isrctn.com/ISRCTN16705062

Intriguing findings! We need to better understand what is really going on in the brain before it bleeds, beyond risk factors! Then, we might be able to treat and prevent (recurrent) ICH. That might become our EURECA one day! Well done!